InvestorsHub Logo
Followers 88
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: None

Thursday, 07/09/2020 7:34:37 AM

Thursday, July 09, 2020 7:34:37 AM

Post# of 64728
TSOI Fields of Study / Right To Try

Therapeutic Solutions International (TSOI) is focused on immune modulation
for the treatment of several specific diseases.


http://therapeuticsolutionsint.com/

TSOI Is On the Right To Try (RTT) Pathway w/ new therapies and adjuvants in these areas of study:
(According to the RTT Law , TSOI will decide which products below will be offered on this pathway)

Stage 1 - 4 Cancers
(Tumor types) - Breast Cancer , Prostate Cancer w/ StemVacs Immunotherapy Platform https://stemvacs.com/ , BRS-001 http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77635806/therapeutic-solutions-international-expands-adopti , NanoStilbeneTM , http://mynanostilbene.com/
Cancer Metabolic DeTox, https://www.globenewswire.com/news-release/2017/05/09/1076506/0/en/Therapeutic-Solutions-files-new-Patent-on-Targeting-the-Tumor-Microenvironment-through-Nutraceutical-Based-Immunoadjuvants.html
and IsoStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77734511/therapeutic-solutions-international-releases-isos
Liver Cancer, Esophageal Cancer, Melanoma (w/ Ipilimumab) NanoStilbeneTM http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80371866/therapeutic-solutions-international-reports-its-na
Breast Cancer, Prostate Cancer, and Ovarian Cancer w/ Ozone therapy , and NanoStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78060284/therapeutic-solutions-international-reports-synerg

Prostate Cancer
w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv

Glioma / Brain Cancers
https://therapeuticsolutionsint.com/?page_id=232 w/ NeuroStilbene , and Brain Cancer Therapeutics https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77868683/therapeutic-solutions-international-inc-release

CTE / Military and Sports Brain Injuries
- (Chronic Traumatic Encephalopathy) w/ JadiCell MSCs (Mesenchymal Stem Cells) https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80242706/therapeutic-solutions-international-obtains-exclus ,
Autologous Neurogenic Stem Cell Banking, http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79022244/therapeutic-solutions-international-continues-to-e
sRNA augmented stem cells, http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78834511/therapeutic-solutions-international-expands-chroni
"Educated" Monocytes / Progenitors, https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79095195/therapeutic-solutions-international-continues-to-e
and NeuroStilbene http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78538984/therapeutic-solutions-international-announces-cte

TBI / mTBI / bTBI (blast TBI) - (Traumatic Brain Injury / mild TBI) w/ JadiCell MSCs, https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80242706/therapeutic-solutions-international-obtains-exclus
and NeuroStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77868683/therapeutic-solutions-international-inc-release

CRS
- (Cytokine Release Syndrome) / Inflammation , Car-T sickness / Immunotherapy side effects w/ NanoStilbeneTM https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78326088/therapeutic-solutions-international-files-patent-o

Diabetes, Cardiovascular Disease, and Neurodegenerative Diseases
w/ Projuvenol ® https://www.biomedreports.com/market-wire/259588-therapeutic-solutions-international-files-patent-covering-projuvenol(c)-and-its-active-ingredient-pterostilbene.html

Neurodegenerative Conditions / Oxidative Brain and Neural Disorders - MS (Multiple Sclerosis), Stroke / post Stroke recovery, and Alzheimers , w/ Alpha Lipoic Acid . https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78013140/therapeutic-solutions-international-develops-micro

Elevated PSA Levels w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv

RA
- (Rheumatoid Arthritis) / Synovitis w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv

TNF (Tumor Necrosis Factor) / Atherosclerosis / TF (Tissue Factor) Elevations, Sepsis, Cardiovascular Disease, RA , Infection w/ NanoStilbene PKE https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79295986/therapeutic-solutions-international-continues-to-r

Covid 19, SARS, ARDS, Breast Cancer, RA, Depression w/ QuadraMune, https://quadramune.com/ , http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82657747/therapeutic-solutions-international-reports-reduct
and NLRP3 Trifecta https://www.youcanordernow.com/NLRP3-Trifecta_p_33.html

Covid 19 w, StemVacs 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-submits-publication-on-stemvacs-preclinical-data-supporting-covid-19-indication-301089133.html


TSOI Right To Try Info & TSOI RTT news:


Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law 5/31/18

https://www.globenewswire.com/news-release/2018/05/31/1514822/0/en/Therapeutic-Solutions-International-to-Provide-Patients-Access-to-StemVacs-Cancer-Immunotherapy-through-Newly-Passed-Right-to-Try-Law.html

Therapeutic Solutions International Announces the Appointment of
James Veltmeyer, MD as Chief Medical Officer 6/18/18

https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77684969/therapeutic-solutions-international-announces-the


TSOI CEO Tim G Dixon receiving the Right To Try Leadership Award (Video) 12/19/18
https://www.facebook.com/tsoihome/videos/2083466298358398/

Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
Company Plans to Advance its Phase I Cancer Immunotherapy StemVacs™ to US Patients 8/5/19

https://www.globenewswire.com/news-release/2019/08/05/1896899/0/en/Therapeutic-Solutions-International-Collaborates-with-Right-to-Try-Foundation-on-Novel-Means-of-Protecting-Patients-While-Hyper-accelerating-Drug-Development.html

FDA Right to Try info for patients
https://www.fda.gov/ForPatients/Other/ucm625115.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News